Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway

ABSTRACT The microbiota-gut-brain axis is a bidirectional communication system that is poorly understood. Alzheimer’s disease (AD), the most common cause of dementia, has long been associated with bacterial infections and inflammation-causing immunosenescence. Recent studies examining the intestinal...

Full description

Bibliographic Details
Main Authors: John P. Haran, Shakti K. Bhattarai, Sage E. Foley, Protiva Dutta, Doyle V. Ward, Vanni Bucci, Beth A. McCormick
Format: Article
Language:English
Published: American Society for Microbiology 2019-06-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mBio.00632-19
_version_ 1818826048176914432
author John P. Haran
Shakti K. Bhattarai
Sage E. Foley
Protiva Dutta
Doyle V. Ward
Vanni Bucci
Beth A. McCormick
author_facet John P. Haran
Shakti K. Bhattarai
Sage E. Foley
Protiva Dutta
Doyle V. Ward
Vanni Bucci
Beth A. McCormick
author_sort John P. Haran
collection DOAJ
description ABSTRACT The microbiota-gut-brain axis is a bidirectional communication system that is poorly understood. Alzheimer’s disease (AD), the most common cause of dementia, has long been associated with bacterial infections and inflammation-causing immunosenescence. Recent studies examining the intestinal microbiota of AD patients revealed that their microbiome differs from that of subjects without dementia. In this work, we prospectively enrolled 108 nursing home elders and followed each for up to 5 months, collecting longitudinal stool samples from which we performed metagenomic sequencing and in vitro T84 intestinal epithelial cell functional assays for P-glycoprotein (P-gp) expression, a critical mediator of intestinal homeostasis. Our analysis identified clinical parameters as well as numerous microbial taxa and functional genes that act as predictors of AD dementia in comparison to elders without dementia or with other dementia types. We further demonstrate that stool samples from elders with AD can induce lower P-gp expression levels in vitro those samples from elders without dementia or with other dementia types. We also paired functional studies with machine learning approaches to identify bacterial species differentiating the microbiome of AD elders from that of elders without dementia, which in turn are accurate predictors of the loss of dysregulation of the P-gp pathway. We observed that the microbiome of AD elders shows a lower proportion and prevalence of bacteria with the potential to synthesize butyrate, as well as higher abundances of taxa that are known to cause proinflammatory states. Therefore, a potential nexus between the intestinal microbiome and AD is the modulation of intestinal homeostasis by increases in inflammatory, and decreases in anti-inflammatory, microbial metabolism. IMPORTANCE Studies of the intestinal microbiome and AD have demonstrated associations with microbiome composition at the genus level among matched cohorts. We move this body of literature forward by more deeply investigating microbiome composition via metagenomics and by comparing AD patients against those without dementia and with other dementia types. We also exploit machine learning approaches that combine both metagenomic and clinical data. Finally, our functional studies using stool samples from elders demonstrate how the c microbiome of AD elders can affect intestinal health via dysregulation of the P-glycoprotein pathway. P-glycoprotein dysregulation contributes directly to inflammatory disorders of the intestine. Since AD has been long thought to be linked to chronic bacterial infections as a possible etiology, our findings therefore fill a gap in knowledge in the field of AD research by identifying a nexus between the microbiome, loss of intestinal homeostasis, and inflammation that may underlie this neurodegenerative disorder.
first_indexed 2024-12-19T00:21:28Z
format Article
id doaj.art-2aebc885e90a4bd7bd0d7aef98886dd4
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-12-19T00:21:28Z
publishDate 2019-06-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-2aebc885e90a4bd7bd0d7aef98886dd42022-12-21T20:45:32ZengAmerican Society for MicrobiologymBio2150-75112019-06-0110310.1128/mBio.00632-19Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein PathwayJohn P. Haran0Shakti K. Bhattarai1Sage E. Foley2Protiva Dutta3Doyle V. Ward4Vanni Bucci5Beth A. McCormick6Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USADepartment of Bioengineering, Program in Engineering and Applied Sciences, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts, USADepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USADepartment of Emergency Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USADepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USADepartment of Bioengineering, Program in Engineering and Applied Sciences, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts, USADepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USAABSTRACT The microbiota-gut-brain axis is a bidirectional communication system that is poorly understood. Alzheimer’s disease (AD), the most common cause of dementia, has long been associated with bacterial infections and inflammation-causing immunosenescence. Recent studies examining the intestinal microbiota of AD patients revealed that their microbiome differs from that of subjects without dementia. In this work, we prospectively enrolled 108 nursing home elders and followed each for up to 5 months, collecting longitudinal stool samples from which we performed metagenomic sequencing and in vitro T84 intestinal epithelial cell functional assays for P-glycoprotein (P-gp) expression, a critical mediator of intestinal homeostasis. Our analysis identified clinical parameters as well as numerous microbial taxa and functional genes that act as predictors of AD dementia in comparison to elders without dementia or with other dementia types. We further demonstrate that stool samples from elders with AD can induce lower P-gp expression levels in vitro those samples from elders without dementia or with other dementia types. We also paired functional studies with machine learning approaches to identify bacterial species differentiating the microbiome of AD elders from that of elders without dementia, which in turn are accurate predictors of the loss of dysregulation of the P-gp pathway. We observed that the microbiome of AD elders shows a lower proportion and prevalence of bacteria with the potential to synthesize butyrate, as well as higher abundances of taxa that are known to cause proinflammatory states. Therefore, a potential nexus between the intestinal microbiome and AD is the modulation of intestinal homeostasis by increases in inflammatory, and decreases in anti-inflammatory, microbial metabolism. IMPORTANCE Studies of the intestinal microbiome and AD have demonstrated associations with microbiome composition at the genus level among matched cohorts. We move this body of literature forward by more deeply investigating microbiome composition via metagenomics and by comparing AD patients against those without dementia and with other dementia types. We also exploit machine learning approaches that combine both metagenomic and clinical data. Finally, our functional studies using stool samples from elders demonstrate how the c microbiome of AD elders can affect intestinal health via dysregulation of the P-glycoprotein pathway. P-glycoprotein dysregulation contributes directly to inflammatory disorders of the intestine. Since AD has been long thought to be linked to chronic bacterial infections as a possible etiology, our findings therefore fill a gap in knowledge in the field of AD research by identifying a nexus between the microbiome, loss of intestinal homeostasis, and inflammation that may underlie this neurodegenerative disorder.https://journals.asm.org/doi/10.1128/mBio.00632-19Alzheimer’s Diseasedementiaelderlygut-brain axisintestinal homeostasisintestinal microbiome
spellingShingle John P. Haran
Shakti K. Bhattarai
Sage E. Foley
Protiva Dutta
Doyle V. Ward
Vanni Bucci
Beth A. McCormick
Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
mBio
Alzheimer’s Disease
dementia
elderly
gut-brain axis
intestinal homeostasis
intestinal microbiome
title Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
title_full Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
title_fullStr Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
title_full_unstemmed Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
title_short Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
title_sort alzheimer s disease microbiome is associated with dysregulation of the anti inflammatory p glycoprotein pathway
topic Alzheimer’s Disease
dementia
elderly
gut-brain axis
intestinal homeostasis
intestinal microbiome
url https://journals.asm.org/doi/10.1128/mBio.00632-19
work_keys_str_mv AT johnpharan alzheimersdiseasemicrobiomeisassociatedwithdysregulationoftheantiinflammatorypglycoproteinpathway
AT shaktikbhattarai alzheimersdiseasemicrobiomeisassociatedwithdysregulationoftheantiinflammatorypglycoproteinpathway
AT sageefoley alzheimersdiseasemicrobiomeisassociatedwithdysregulationoftheantiinflammatorypglycoproteinpathway
AT protivadutta alzheimersdiseasemicrobiomeisassociatedwithdysregulationoftheantiinflammatorypglycoproteinpathway
AT doylevward alzheimersdiseasemicrobiomeisassociatedwithdysregulationoftheantiinflammatorypglycoproteinpathway
AT vannibucci alzheimersdiseasemicrobiomeisassociatedwithdysregulationoftheantiinflammatorypglycoproteinpathway
AT bethamccormick alzheimersdiseasemicrobiomeisassociatedwithdysregulationoftheantiinflammatorypglycoproteinpathway